Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549653 · ClinicalTrials.gov registry record · Phase 1
A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT00549653 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 44 participants.
The verdict
NCT00549653, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study is being conducted to provide initial safety and tolerability data as well as to provide PK data on potential interactions when GW856553 and rosuvastatin are co-administered in healthy male adults
Interventions
- DRUG GW856553
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2007-10 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00549653
The ClinicalTrials.gov registry entry for NCT00549653 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GW856553 is the first listed.
NCT00549653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00549653 about?
NCT00549653 is a clinical study titled "A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men". This study is being conducted to provide initial safety and tolerability data as well as to provide PK data on potential interactions when GW856553 and rosuvastatin are co-administered in healthy male adults
What is the current status of trial NCT00549653?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2007-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00549653?
The interventions under investigation include: GW856553 (DRUG).
Who is sponsoring clinical trial NCT00549653?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.